Nexen, Moody’s, and More: Billionaire Thomas Steyer’s New Stock Picks

Billionaire Thomas Steyer serves as a managing member of Farallon Capital Management, one of the largest hedge funds in the world. Farallon’s fundamental analysis encompasses strategies including pure value, merger arbitrage, and event-driven investments. The fund recently filed its 13F for the third quarter of the year, and by comparing this filing to the one for the second quarter we can see which stocks Steyer and his team added to their portfolio. Read on for our quick take on the five largest new positions that Farallon reported in its 13F portfolio and compare its holdings to those in previous filings.

Thomas-Steyer-e1351513531594

The fund’s largest new holding was takeover target Nexen Inc. (NYSE:NXY), an oil and gas exploration and production company which is notable for its position in Alberta’s Athabasca oil sands. A number of hedge funds have gotten into this stock, because merger arbitrage offers returns that tend to have a low correlation with the broader market- profits and losses depend solely on whether or not the deal closes (read more about merger arbitrage strategies). In this case there’s a real concern that the deal will be struck down by the Canadian government, as the public is wary of seeing Canadian assets sold to Chinese oil company CNOOC. We’re not certain that the deal will be approved, so we’d avoid investing.

Another new stock pick was $3 billion market cap engineering services company The Shaw Group Inc. (NYSE:SHAW), with Farallon owning 2.2 million shares at the end of September. Shaw is up 85% in the last year, and still trades at 16 times earnings on either a trailing or a forward basis. Cliff Asness’s AQR Capital Management moved heavily into the stock during the third quarter as well (see more of Cliff Asness’s stock picks). We think that the company is worth a look, though it doesn’t appear to have been growing its revenues recently and at that pricing we’d like to see at least somewhat better numbers.

Electrical components and protective devices company Cooper Industries plc (NYSE:CBE) was another new long in the portfolio as Steyer and his team bought 1 million shares between July and September. In the third quarter of 2012 Cooper reported that its revenue and net income had risen 8% and 18%, respectively, from their levels in the same period in 2011. The stock is priced for continued growth at 18 times trailing earnings, and our impression is that its industry would be somewhat stable going forward, so we’d need to check to see that it can maintain a double-digit growth rate.

Farallon initiated a position of 1.5 million shares in Check Point Software Technologies Ltd. (NASDAQ:CHKP). Check Point is an IT security company with a market capitalization of $9.4 billion, which places it at P/E multiples in the teens as well. A 17% drop in the stock price in the last year- combined with an earnings increase of 14% between Q3 2011 and last quarter- have placed it at 16 times trailing earnings, with analysts expecting continued growth in 2013. It’s also a stock that might be worth taking a close look at.

It’s a similar story with Moody’s Corporation (NYSE:MCO): it’s a well capitalized stock trading at a trailing P/E of 18, and in its most recent quarter reported 41% earnings growth (off of a 30% rise in revenue) compared to the same period in the previous year. It’s clearly a good stock to buy if it can continue that performance, or even something close to it. Yet here we see fairly high short interest- 9% of the shares outstanding are held short- so there’s clearly disagreement in the market, and as with some of the other companies we’ve discussed here it would be important to review Moody’s in more depth.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!